Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Number 10138299
US 10138299 B2Filled DateJun 12, 2018
Priority DateMay 15, 2012
Publication DateOct 4, 2018
Expiration DateMay 14, 2032
Inventor/ApplicantsJohn P. Cogswell
Xi-Tao Wang
Ashok K. Gupta
Jon M. Wigginton
Stacie M. GOLDBERG
John P. COGSWELL
Xi-Tao WANG
Ashok K. GUPTA
Maria Jure-Kunkel
Stacie M. Goldberg
Maria JURE-KUNKEL
Jon M. WIGGINTON
Xi-Tao Wang
Ashok K. Gupta
Jon M. Wigginton
Stacie M. GOLDBERG
John P. COGSWELL
Xi-Tao WANG
Ashok K. GUPTA
Maria Jure-Kunkel
Stacie M. Goldberg
Maria JURE-KUNKEL
Jon M. WIGGINTON
ExaminesOUSPENSKI, ILIA I
Art Unit1644
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.